Peripartum cardiomyopathy: a case report and literature review

Authors

  • Alejandro Hernández-Guzmán
  • Albaro José Nieto-Calvache
  • Virna Medina-Palmezano
  • Julián Delgado-Gutiérrez

DOI:

https://doi.org/10.18597/rcog.335

Keywords:

peripartum cardiomyopathy, cardiac failure, pregnancy

Abstract

Objective: reviewing the relevant literature concerning medical care and management in a peripartum cardiomyopathy (PPCM) high obstetrical dependence unit.

Case report: this article presents a case diagnosed as having PPCM on the 4th day postpartum. An echocardiogram revealed a compromised ejection fraction. Intensive, appropriate treatment led to survival and recovery of left ventricular systolic function.

Discussion: PPCM is a rare cardiac disorder which occurs during the peripartum period. It has been recognised as a distinct entity from myocardial infarction. Its exact incidence remains unknown but mortality rate ranges from 9% to 56%, most deaths being reported during the first three months postpartum. Diagnosis is based upon the clinical presentation of congestive heart failure and objective evidence of left ventricular systolic dysfunction. Treatment should include standard therapy for heart failure, thus implying reduced preload, postload and inotropic, diuretic, vasodilator agents and digoxin use. Angiotensin-converting enzyme inhibitors (ACEI) must be included in CMPP postpartum treatment. The outcome of pregnancy depends on functional state and response to initial treatment. The obstetrician plays a fundamental role in a multidisciplinary approach to females suffering from this entity and must coordinate team efforts.

Author Biographies

Alejandro Hernández-Guzmán

Residente de Ginecología y Obstetricia. Universidad del Valle. Hospital Universitario del Valle. Departamento de Ginecología y Obstetricia. Dirección: calle 5 No. 36-05. (Cali, Colombia).

Albaro José Nieto-Calvache

Residente de Ginecología y Obstetricia. Universidad del Valle. Hospital Universitario del Valle. Departamento de Ginecología y Obstetricia. Dirección: calle 5 No. 36-05. (Cali, Colombia).

Virna Medina-Palmezano

Especialista en Ginecología y Obstetricia. Universidad del Valle. Profesora Contratista, Departamento de Ginecología y Obstetricia. Universidad del Valle (Cali, Colombia).

 

Julián Delgado-Gutiérrez

MSc en Obstetricia. Universidad Autónoma de Barcelona (España). Especialista en Ginecología y Obstetricia. Universidad del Valle. Profesor Asistente, Departamento de Ginecología y Obstetricia. Universidad del Valle (Cali, Colombia).

 

References

Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971;44:964-8.

Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002;186:1005-10.

Cenac A, Djibo A. Postpartum cardiac failure in Sudanese-Sahelian Africa: clinical prevalence in western Niger. Am J Trop Med Hyg 1998;58:319-23.

Lang CT, King JC. Maternal mortality in the United States. Best Pract Res Clin Obstet Gynaecol 2008;22:517-31.

Ray P, Murphy GJ, Shutt LE. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth 2004;93:428-39.

Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-93.

Arafeh JM, Baird SM. Cardiac disease in pregnancy. Crit Care Nurs Q 2006;29:32-52.

Palmer DG. Peripartum cardiomyopathy. J Perinat Neonat Nurs 2006;20:324-32.

Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med 2005;33:S340-6.

Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982;307:731-4.

Cenac A, Djibo A, Sueur JM, Chaigneau C, Orfila J. Chlamydia infection and peripartum dilated cardiomyopathy in Niger. Med Trop 2000;60:137-40.

Arnould N, Diemunsch P, Raiga J, Brettes JP. Peripartum dilated cardiomyopathies: is there a correlation with sexually transmitted diseases? Gynecol Obstet Fertil 2002;30:59-63.

Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363-5.

Cunningham FG, Pritchard JA, Hankins GD, Anderson PL, Lucas MJ, Armstrong KF. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events. Obstet Gynecol 1986;67:157-68.

Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002;23:301-24.

James PR. A review of peripartum cardiomyopathy. Int J Clin Pract 2004;58:363-5.

Kothari SS. Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? Int J Cardiol 1977;60:111-4.

Mielniczuk L, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 2006;97:1765-8.

Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B, et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008;199:415.e1-5.

Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8.

Ro A, Frishman WH. Peripartum cardiomyopathy. Cardiol Rev 2006;14:35-42.

Witlin AG, Mabie WC, Sibai BM.Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 1997;176:182-8.

Lang RM, Lampert MB, PoppasA, et al. En: Elkayam U, Gleicher N, editors. Cardiac problem in pregnancy: diagnosis and management of maternal and fetal disease. 3rd Ed. New York: Wiley-Liss; 1998. p.87.

Abbas AE, Lester SJ, Connolly H. Pregnancy and cardiovascular system. Int J Cardiol 2005;98:179-89.

Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005;105:1303-8.

Witlin AG, Mabie WC, Sibai BM.Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 1997;177:1129-32.

Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G, et al. Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis. J Heart Lung Transplant 2007;26:1097-104.

Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84.

Fett J, Christie L. Brief communication: outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 2006;145:30-4.

Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.

Amos A, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006;152:509-13.

ManolioTA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol 1992:69:1458-66.

How to Cite

1.
Hernández-Guzmán A, Nieto-Calvache AJ, Medina-Palmezano V, Delgado-Gutiérrez J. Peripartum cardiomyopathy: a case report and literature review. Rev. colomb. obstet. ginecol. [Internet]. 2009 Sep. 30 [cited 2024 May 18];60(3):294-9. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/335

Downloads

Download data is not yet available.

Published

2009-09-30
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: